Lauterbach expects a quick start for the BA.5 vaccine


Federal Health Minister Karl Lauterbach (SPD)

The vaccination is recommended for people over the age of twelve as a refresher.

(Photo: IMAGO/photothek)

revote Federal Minister of Health Karl Lauterbach expects a quick start of corona vaccinations with the approved new preparation, which is adapted to the virus variant BA.5. "We will probably make the vaccine available as early as next week," he said SPDpoliticians on Tuesday on the sidelines of a visit to Israel in Rechovot near Tel Aviv.

First doses of vaccine from Biontech are to be delivered to pharmaceutical wholesalers next Monday and Tuesday (September 19/20), according to a letter from Lauterbach to all service providers of the vaccination campaign, such as doctors. Should be until October 3rd Germany received around 19 million doses for the time being. Exact delivery schedules are still to be coordinated.

"I'm glad that this vaccine has now been approved as expected," said Lauterbach. "So we have two very good adapted vaccines that we can offer and will therefore be able to vaccinate everyone who wants to be vaccinated in the next few weeks."

the European Commission had the other vaccine from the manufacturer on Monday Biontech and Pfizer approved, which is adapted to the Omikron sub-lines BA.4 and BA.5. The vaccination is recommended for people over the age of twelve as a booster, said the EU medicines authority Ema. A new vaccine adapted to variant BA.1 was recently approved.

Top jobs of the day

Find the best jobs now and
be notified by email.

Lauterbach commented on the conclusion of a four-day visit to Israel after a visit to the Weizmann Research Institute in Rechovot. "Israel shows what a country can do when it spends heavily on science and research," he said. This was shown by spectacular results in many areas, such as cancer treatment or the development of Alzheimer's and Parkinson's.

More: Lauterbach in the promised Corona land: What Germany can learn from Israel in the pandemic



Source link